These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28791609)

  • 1. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
    Moonen M; Oury C; Lancellotti P
    Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
    Akhter N; Murtagh G; Yancy C
    Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
    Garg V; Vorobiof G
    Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Myocardial Strain Imaging in Cancer Therapy-Related Cardiac Dysfunction.
    Chaganti BT; Negishi K; Okajima K
    Curr Cardiol Rep; 2022 Jun; 24(6):739-748. PubMed ID: 35522421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current recommendations for diagnostic echocardiography in cancer patients : Is echocardiography too late or too early?].
    Kruck I
    Herz; 2017 May; 42(3):262-270. PubMed ID: 28233035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of echocardiography in monitoring of cardiac toxicity of cancer pharmacotherapy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging].
    Piotrowski G; Gawor R; Gawor Z; Szmit S; Kasprzak JD; Miśkiewicz Z; Opolski G; Torbicki A; Krzakowski M; Filipiak KJ; Szyszka A; Płońska-Gościniak E;
    Kardiol Pol; 2014; 72(6):558-75. PubMed ID: 24961458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiography and cancer therapeutics-related cardiac dysfunction.
    Tanaka H
    J Med Ultrason (2001); 2019 Jul; 46(3):309-316. PubMed ID: 31030300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
    Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
    Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced imaging modalities to detect cardiotoxicity.
    Awadalla M; Hassan MZO; Alvi RM; Neilan TG
    Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
    Yu AF; Raikhelkar J; Zabor EC; Tonorezos ES; Moskowitz CS; Adsuar R; Mara E; Huie K; Oeffinger KC; Steingart RM; Liu JE
    Biomed Res Int; 2016; 2016():9363951. PubMed ID: 26942202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques.
    Di Lisi D; Manno G; Novo G
    Curr Probl Cardiol; 2021 Jun; 46(6):100818. PubMed ID: 33756178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of myocardial strain imaging in surveillance and management of cancer therapeutics-related cardiac dysfunction: A systematic review.
    McGregor PC; Moura FA; Banchs J; Aragam JR
    Echocardiography; 2021 Feb; 38(2):314-328. PubMed ID: 33277729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of left ventricular strain measurements to patients undergoing chemotherapy.
    Clasen SC; Scherrer-Crosbie M
    Curr Opin Cardiol; 2018 Sep; 33(5):493-497. PubMed ID: 30028729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of echocardiography in the assessment of cancer-related cardiac dysfunction].
    Mele D; Nardozza M
    G Ital Cardiol (Rome); 2017 Nov; 18(11):764-773. PubMed ID: 29105671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
    Valzania C; Paccagnella A; Spadotto A; Ruotolo I; Bonfiglioli R; Fallani F; Fanti S; Galié N
    J Nucl Cardiol; 2023 Oct; 30(5):2104-2111. PubMed ID: 36855007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity due to chemotherapy: role of cardiac imaging.
    Poulin F; Thavendiranathan P
    Curr Cardiol Rep; 2015 Mar; 17(3):564. PubMed ID: 25648628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
    Hernandez-Suarez DF; López-Candales A
    Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
    Soufer A; Liu C; Henry ML; Baldassarre LA
    J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.